199 related articles for article (PubMed ID: 35662635)
1. Modified release kinetics in dual filament 3D printed individualized oral dosage forms.
Tidau M; Finke JH
Eur J Pharm Sci; 2022 Aug; 175():106221. PubMed ID: 35662635
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
[TBL] [Abstract][Full Text] [Related]
3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and
Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial 3D printed dosage forms for a two-step and controlled drug release.
Katsiotis CS; Tikhomirov E; Strømme M; Lindh J; Welch K
Eur J Pharm Sci; 2023 Aug; 187():106486. PubMed ID: 37277047
[TBL] [Abstract][Full Text] [Related]
6. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
7. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
8. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
10. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA
Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014
[TBL] [Abstract][Full Text] [Related]
11. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
12. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
[TBL] [Abstract][Full Text] [Related]
13. QbD guided development of immediate release FDM-3D printed tablets with customizable API doses.
Crișan AG; Iurian S; Porfire A; Rus LM; Bogdan C; Casian T; Lucacel RC; Turza A; Porav S; Tomuță I
Int J Pharm; 2022 Feb; 613():121411. PubMed ID: 34954001
[TBL] [Abstract][Full Text] [Related]
14. Controlled Release of 5-Fluorouracil from Alginate Beads Encapsulated in 3D Printed pH-Responsive Solid Dosage Forms.
Gioumouxouzis CI; Chatzitaki AT; Karavasili C; Katsamenis OL; Tzetzis D; Mystiridou E; Bouropoulos N; Fatouros DG
AAPS PharmSciTech; 2018 Nov; 19(8):3362-3375. PubMed ID: 29948989
[TBL] [Abstract][Full Text] [Related]
15. 3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles.
Enke M; Schwarz N; Gruschwitz F; Winkler D; Hanf F; Jescheck L; Seyferth S; Fischer D; Schneeberger A
Int J Pharm; 2023 Jul; 642():123101. PubMed ID: 37295568
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
17. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
[TBL] [Abstract][Full Text] [Related]
18. 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and Prediction.
Korte C; Quodbach J
AAPS PharmSciTech; 2018 Nov; 19(8):3333-3342. PubMed ID: 29855799
[TBL] [Abstract][Full Text] [Related]
19. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.
Alhnan MA; Okwuosa TC; Sadia M; Wan KW; Ahmed W; Arafat B
Pharm Res; 2016 Aug; 33(8):1817-32. PubMed ID: 27194002
[TBL] [Abstract][Full Text] [Related]
20. 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms.
Krueger L; Miles JA; Popat A
J Control Release; 2022 Nov; 351():444-455. PubMed ID: 36184971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
